Related Experiment Video
Updated: Jan 28, 2026

Analysis of Human Natural Killer Cell Metabolism
Published on: June 22, 2020
Suppression of Human Natural Killer Cells by Different Classes of Opioids
Dermot P Maher1, Deepa Walia, Nicola M Heller
1From the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
Background:
The use of regional and other opioid-sparing forms of anesthesia has been associated with a decrease in the recurrence of certain malignancies. Direct suppression of human natural killer cells by opioids has been postulated to explain this observation. However, the effect of different classes of opioids on suppression of natural killer cell cytotoxicity has not been systematically characterized.
Methods:
After confirming that freshly isolated natural killer cells from peripheral human blood express opioid receptors, cells were incubated with increasing concentrations of clinically used or receptor-specific opioid agonists. We also evaluated the effect of pretreatment with receptor-specific antagonists or naloxone. Treated natural killer cells were then coincubated with a carboxyfluorescein succinimidyl ester-labeled target tumor cell line, K562. Annexin V staining was used to compare the percent of tumor cell apoptosis in the presence of opioid-pretreated and untreated natural killer cells. Treated samples were compared to untreated samples using Kruskal-Wallis tests with a post hoc Dunn correction.
Results:
Morphine, methadone, buprenorphine, loperamide, [D-Ala2, N-MePhe4, Gly-ol]-enkephalin, and U-50488 significantly decreased natural killer cell cytotoxicity. When natural killer cells were pretreated with naloxone, cyprodime, and nor-binaltorphimine before exposure to morphine, there was no difference in natural killer cytotoxicity, compared to the amount observed by untreated natural killer cells. Fentanyl, O-desmethyltramadol, and [D-Pen2,D-Pen5] enkephalin did not change natural killer cell cytotoxicity compare to untreated natural killer cells.
Conclusions:
Incubation of isolated natural killer cells with certain opioids causes a decrease in activity that is not observed after naloxone pretreatment. Suppression of natural killer cell cytotoxicity was observed with μ- and κ-receptor agonists but not δ-receptor agonists. These data suggest that the effect is mediated by μ- and κ-receptor agonism and that suppression is similar with many clinically used opioids.
Insights
Certain opioids suppress natural killer cell activity, potentially explaining reduced cancer recurrence with opioid-sparing anesthesia. This effect is mediated by mu- and kappa-receptor agonism, not delta-receptors.
Area of Science:
- Immunology
- Pharmacology
- Anesthesiology
Background:
- Opioid-sparing anesthesia is linked to decreased cancer recurrence.
- Opioids may suppress natural killer (NK) cell activity, a potential mechanism.
- Systematic characterization of opioid class effects on NK cell cytotoxicity is lacking.
Purpose of the Study:
- To investigate the impact of various opioid classes on human natural killer cell cytotoxicity.
- To determine the receptor subtypes involved in opioid-mediated NK cell suppression.
Main Methods:
- Human NK cells were isolated and incubated with clinically relevant opioids and receptor-specific agonists.
- NK cell cytotoxicity was assessed by measuring tumor cell apoptosis after co-incubation.
- The role of opioid receptor antagonists, including naloxone, was evaluated.
Main Results:
- Morphine, methadone, buprenorphine, loperamide, and specific agonists ([D-Ala2, N-MePhe4, Gly-ol]-enkephalin, U-50488) significantly reduced NK cell cytotoxicity.
- Fentanyl, O-desmethyltramadol, and [D-Pen2,D-Pen5] enkephalin did not affect NK cell cytotoxicity.
- Naloxone pretreatment blocked opioid-induced suppression, indicating receptor-mediated effects.
Conclusions:
- Certain opioids, particularly mu- and kappa-receptor agonists, suppress human NK cell cytotoxicity.
- This suppression is reversible with naloxone, confirming receptor involvement.
- Findings suggest a mechanism linking opioid use, NK cell function, and cancer recurrence.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
What is Natural Selection?
Nature and Nurture
Drug Classes and Categories

